SecBot SecBot
Insider Cluster (2 insiders) ·Filed Mar 13, 2026

CNTA

Centessa Pharmaceuticals plc
BEARISH
Impact 6/10
Horizondays Processed8mo ago
Insider cluster: 2 insiders, $4.4M total
Actionable Insight ▼ Bearish

Traders should monitor for potential downward pressure on CNTA shares, especially if this selling follows weak clinical data, lack of near-term catalysts, or broader biotech sector weakness. Assess whether this is part of a routine post-vesting disposition or a signal of deteriorating confidence.

DirectionBearish
Confidencehigh
Horizondays

How the stock moved after the report

⚠ Clustered BEARISH VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$28.29
T+0 close · Mar 13, 2026 · via day close
Latest settled
+40.30%
T+60 · $39.69
Vs SPY
+31.87%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Mar 16 $28.29entry
  2. T+1 · 8mo ago +2.33%α +2.07% · $28.95
  3. T+5 · 8mo ago −8.31%α −6.27% · $25.94
  4. T+20 · 7mo ago +39.94%α +36.14% · $39.59
  5. T+60 · 5mo ago +40.30%α +31.87% · $39.69
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Centessa Pharmaceuticals insiders executed a significant share disposition cluster within one day, led by the Chief People Officer selling $2.82M in shares and exercising derivatives, alongside the Chief Business Officer selling $1.6M. The total open-market sales amount to $4.43M, representing a notable insider selling event.

Key Financial Metrics

Direction
selling
Total Value
$4.4M
Insiders
2

Key Facts

  • Chief People Officer Karen M. Anderson sold 107,961 shares for $2,823,234 in open-market transactions.
  • Anderson also exercised derivative securities involving 218,796 shares with a total cost basis of $438,686, resulting in no cash inflow for the company.
  • Chief Business Officer Gregory M. Weinhoff sold 61,253 shares for $1,602,795 in open-market transactions.
  • Total open-market proceeds from insider sales: $4,426,029 over a single day.

Financial Impact

$4.43M in open-market insider sales over one day, representing ~0.11% of Centessa's $3.9B market cap

insider ownershipinvestor sentimentshare supply

Risk Factors

  • Insider selling may signal lack of confidence in near-term prospects, particularly from C-suite executives.
  • Risk of negative market perception amplifying selling pressure, especially in a volatile biotech environment.

Market Snapshot

Exchange
Nasdaq

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CONTEXT: Insider Cluster Data (4 trades, 7d window)cluster-CNTA-1773440631845

Track record

5 reports on CNTA

Performance horizon

1 of 3 bullish or bearish reports moved the stock their way by T+5. Best: +8.31% at T+5 after the Mar 13, 2026 report. 3 of 3 went positive at some point.

Filters
  1. Jul 6, 202619w ago 15-12G Bearish 7/10 No price data
  2. Apr 17, 202630w ago PREM14A Bullish 9/10 Entry $39.51 to $39.51 · 0.00% −0.91% vs SPY
  3. Apr 13, 202631w ago DEFA14A Bullish 8/10 Entry $39.59 to $39.49 ▼ −0.25% −1.65% vs SPY
  4. Mar 13, 202635w ago Insider Cluster Bearish 7/10 Entry $28.29 to $25.94 ▲ +8.31% +6.27% vs SPY
  5. Mar 13, 202635w ago Insider Cluster Bearish 6/10 Viewing Entry $28.29 to $25.94 ▲ +8.31% +6.27% vs SPY
Showing 5 of 5

US Market Status

Market Closed · Opens Wed (11h 56m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Mar 13, 2026